Effect of sputum quality and role of Xpert
Xpert® MTB/RIF test
diagnostic performance
smear-negative pulmonary tuberculosis
sputum quality
tuberculosis culture
Journal
African journal of laboratory medicine
ISSN: 2225-2002
Titre abrégé: Afr J Lab Med
Pays: South Africa
ID NLM: 101603205
Informations de publication
Date de publication:
2022
2022
Historique:
received:
08
07
2021
accepted:
24
05
2022
entrez:
12
9
2022
pubmed:
13
9
2022
medline:
13
9
2022
Statut:
epublish
Résumé
There is limited information on the performance of the Xpert This study aimed to determine the performance of the Xpert A cross-sectional study was conducted from August 2017 to January 2018 across 16 health facilities in Addis Ababa, Ethiopia. Two spot sputum samples were collected from 418 presumptive SNPT patients, tested with Xpert® MTB/RIF, then compared to tuberculosis culture. Additionally, culture isolates were tested for RR by BACTEC MGIT™ 960 drug susceptibility testing (DST) and MTBDRplus version 2. The Xpert The performance of the Xpert
Sections du résumé
Background
UNASSIGNED
There is limited information on the performance of the Xpert
Objective
UNASSIGNED
This study aimed to determine the performance of the Xpert
Methods
UNASSIGNED
A cross-sectional study was conducted from August 2017 to January 2018 across 16 health facilities in Addis Ababa, Ethiopia. Two spot sputum samples were collected from 418 presumptive SNPT patients, tested with Xpert® MTB/RIF, then compared to tuberculosis culture. Additionally, culture isolates were tested for RR by BACTEC MGIT™ 960 drug susceptibility testing (DST) and MTBDRplus version 2.
Results
UNASSIGNED
The Xpert
Conclusion
UNASSIGNED
The performance of the Xpert
Identifiants
pubmed: 36091348
doi: 10.4102/ajlm.v11i1.1671
pii: AJLM-11-1671
pmc: PMC9453192
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1671Subventions
Organisme : FIC NIH HHS
ID : D43 TW009127
Pays : United States
Informations de copyright
© 2022. The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no financial or personal relationships that may have inappropriately influenced them in writing this article.
Références
Int J Tuberc Lung Dis. 2002 Mar;6(3):222-30
pubmed: 11934140
Sci Rep. 2014 Jul 11;4:5658
pubmed: 25014250
Pan Afr Med J. 2014 Oct 16;19:162
pubmed: 25810798
Int J Tuberc Lung Dis. 2016 Mar;20(3):319-22
pubmed: 27046711
J Pathog. 2017;2017:6738095
pubmed: 29225973
BMC Infect Dis. 2019 Jan 7;19(1):18
pubmed: 30616533
Public Health Action. 2018 Mar 21;8(1):2-6
pubmed: 29581936
PLoS One. 2017 Jul 7;12(7):e0180572
pubmed: 28686705
Diagn Microbiol Infect Dis. 2012 Oct;74(2):207-9
pubmed: 22819240
PLoS One. 2017 Apr 21;12(4):e0176186
pubmed: 28430807
PLoS One. 2016 Jan 25;11(1):e0147933
pubmed: 26808299
Cochrane Database Syst Rev. 2014 Jan 21;(1):CD009593
pubmed: 24448973
BMC Microbiol. 2015 Oct 19;15:220
pubmed: 26483194
Public Health Action. 2014 Dec 21;4(4):243-8
pubmed: 26400703
BMC Infect Dis. 2020 Jan 30;20(1):87
pubmed: 32000702
Lancet Infect Dis. 2013 Feb;13(2):102-4
pubmed: 23099182
Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S145-S146
pubmed: 28043515
BMC Infect Dis. 2019 Jul 19;19(1):641
pubmed: 31324227
PLoS One. 2019 Nov 12;14(11):e0225205
pubmed: 31714934
J Clin Microbiol. 2013 Jul;51(7):2311-6
pubmed: 23678061
Diagn Microbiol Infect Dis. 2021 Jul;100(3):115363
pubmed: 33743471
Int J Tuberc Lung Dis. 2015 May;19(5):537-44
pubmed: 25868021
Clin Infect Dis. 2008 Nov 1;47(9):1135-42
pubmed: 18823268
BMC Infect Dis. 2012 Aug 01;12:172
pubmed: 22853561
Thorax. 2004 Apr;59(4):286-90
pubmed: 15047946
BMC Infect Dis. 2016 Nov 8;16(1):660
pubmed: 27825314
PLoS Med. 2011 Jul;8(7):e1001067
pubmed: 21818180
PLoS Med. 2011 Nov;8(11):e1001120
pubmed: 22087078
Int J Tuberc Lung Dis. 2017 Apr 1;21(4):389-397
pubmed: 28284253
J Lab Physicians. 2016 Jul-Dec;8(2):96-100
pubmed: 27365918
Clin Microbiol Rev. 2011 Apr;24(2):314-50
pubmed: 21482728
Tubercle. 1980 Jun;61(2):113-5
pubmed: 6776672